Natco Pharma Ltd Board of Directors
Board of Directors at Natco Pharma Ltd
A D Murthy Chavali
Independent Director
B. Lakshminarayana
Independent Director
D Rao
President & Director
Kantipudi Suma
Independent Director
Nitin Jain
Independent Director
Key Highlights
- V C Nannapaneni continues to serve as the Chairman / Executive Director / M D / Promoter in 2026, maintaining the same position as in the previous year.
- Rajeev Nannapaneni joins the board as Vice Chairman & CEO, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- PSRK Prasad continues to serve as the ED / EVP in 2026, maintaining the same position as in the previous year.
- D Linga Rao joins the board as ED & President (Corporate affa, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- A D Murthy Chavali continues to serve as the Independent Non Exe. Director in 2026, maintaining the same position as in the previous year.
Natco Pharma Ltd
NSE: NATCOPHARM
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 30 Oct 2026 | 782.5 |
| 29 Oct 2026 | 787.75 |
| 28 Oct 2026 | 793.35 |
| 27 Oct 2026 | 794.05 |
| 26 Oct 2026 | 790.1 |
| 23 Oct 2026 | 792.2 |
| 22 Oct 2026 | 785.5 |
| 21 Oct 2026 | 784.9 |
| 19 Oct 2026 | 800.75 |
| 16 Oct 2026 | 785.25 |
Company Fundamentals for Natco Pharma Ltd
Market Cap
15,350 Cr
EPS
58.3
P/E Ratio (TTM)
13.4
P/B Ratio (TTM)
1.5
Day’s High
801.15
Day’s Low
780.0
DTE
0.1
ROE
15.4
52 Week High
1216.19
52 Week Low
774.0
ROCE
15.4
Market Price of Natco Pharma Ltd
1M
1Y
3Y
5Y
Monitoring Natco Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Natco Pharma Ltd News Hub
Natco Pharma invests USD 8 mn in bio-tech firm eGenesis
Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) Inc. has mad
Read more
04 Sept 24
Natco Pharma fixes record date for second interim dividend
Natco Pharma has fixed 23 August 2024 as record date for second interim dividend for FY 2024-25. The
Read more
12 Aug 24
Board of Natco Pharma recommends dividend
Natco Pharma announced that the Board of Directors of the Company at its meeting held on 12 August 2
Read more
12 Aug 24
Natco Pharma schedules AGM
Natco Pharma announced that the 41th Annual General Meeting (AGM) of the company will be held on 30
Read more
12 Aug 24
Document
Popular Search
FAQs for Board of Directors of Natco Pharma Ltd
How are members of Natco Pharma Ltd Board of Directors selected?
Members of the Natco Pharma Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Natco Pharma Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Natco Pharma Ltd Board of Directors?
Shareholders can interact with the Natco Pharma Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Natco Pharma Ltd Board of Directors meet?
The Natco Pharma Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Natco Pharma Ltd Board of Directors?
The Natco Pharma Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Natco Pharma Ltd?
The current Board of Directors at Natco Pharma Ltd includes V C Nannapaneni( Chairman / Executive Director / M D / Promoter) ,Rajeev Nannapaneni( Vice Chairman & CEO) ,PSRK Prasad( ED / EVP) ,D Linga Rao( ED & President (Corporate affa) ,A D Murthy Chavali( Independent Non Exe. Director) . The full list can be found on Natco Pharma Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
